Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Results of ARIES-HM3 demonstrate use of aspirin was associated with an increased rate of major bleeding following HeartMate 3 implantation. 

ARIES-HM3: Aspirin Increases Bleeding Risk Following LVAD Implantation

Anthos Therapeutics halts their phase 2 AZALEA-TIMI 71 trial due to significant reduction in bleeding events with abelacimab, making it a potential breakthrough in anticoagulation therapy for atrial fibrillation.

Abelacimab Demonstrates "Overwhelming" Efficacy vs Rivaroxaban in Phase 2b Trial

A secondary analysis of ASPREE is bringing the role of aspirin in primary prevention settings further into question, suggesting daily use of low-dose aspirin was associated with a 38% increase in intracranial bleeding in older adults.

Risk of Brain Bleeds with Aspirin May Outweigh Stroke Reduction Benefit for Older Adults

Physical activity concentrated within a 1- to 2-day span was associated with a similarly lower risk of cardiovascular outcomes to more evenly distributed activity. 

Weekend Warrior Activity Patterns Associated with Low Risk of Cardiovascular Outcomes

An analysis of patient data from the greater Houston area suggests women were less likely to be routed to a comprehensive stroke center than their male counterparts, despite a greater symptom severity and comparable distance to the centers. 

Women with Acute Ischemic Stroke Less Likely to Receive Optimal Stroke Care

Presented at the European Stroke Conference, results of the ELAN trial offer evidence in support of early initiation, as opposed to later initiation, strategies for anticoagulation following acute ischemic stroke in patients with atrial fibrillation.

ELAN Trial: Early Initiation of DOACs Reduces Event Risk after Stroke Event

A single-center study from India sheds light on the safety and efficacy of biosimilar tenecteplase relative to the reference agent for patients with acute ischemic stroke. 

Biosimilar Tenecteplase Demonstrates Utility vs Reference Agent for Acute Ischemic Stroke

In an interview at ACC 2023, Harrington elaborated on the upcoming phase 3 Librexia clinical trial program studying the Factor XIa inhibitor for the prevention of thrombotic events. 

Robert Harrington, MD: Importance of Phase 3 Trial Program Evaluating Milvexian

New data from a predefined secondary analysis of the STROKE-AF trial provides insight into the 3-year incidence of atrial fibrillation among patients with a history of ischemic stroke caused by atherosclerosis. 

3-Year Data from STROKE-AF Underscores Ability of ICM in Stroke Patients

An analysis of data from the China Kadoorie Biobank study suggests cumulative exposure to estrogen was associated with stroke risk in postmenopausal women. 

Elevated Lifetime Estrogen Exposure Could Increase Stroke Risk in Women

On the HCPLive stroke page, resources on the topics of medical news and expert insight into CVA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on stroke medicine, and more.